03682nam a22005895i 4500 978-3-031-50415-0 DE-He213 20251030112933.0 cr nn 008mamaa 240903s2024 sz | s |||| 0|eng d 9783031504150 978-3-031-50415-0 10.1007/978-3-031-50415-0 doi RM300-666 MMG bicssc MED071000 bisacsh MKG thema Mittal, Bhavishya. author. aut http://id.loc.gov/vocabulary/relators/aut 83587 Sustainable Global Health Systems and Pharmaceutical Development [electronic resource] / by Bhavishya Mittal. 1st ed. 2024. Cham : Springer International Publishing : Imprint: Springer, 2024. XXIX, 247 p. 109 illus., 92 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda AAPS Advances in the Pharmaceutical Sciences Series, 2210-738X ; 60 Health Care Industry -- Reimbursement and Pricing -- Current Stage of Pharmaceutical Development -- Desired Future State of Pharmaceutical Development -- Case Studies I -- Case Studies II -- Case Studies III. Despite being an economically intense activity, the current state of drug product development makes a limited effort to integrate economics into product design and development. For example, pharmaceutical scientists are excellent at a data-driven decision-making process that requires technical elements and a few strategic elements. However, there is minimal integration of financial valuation elements (commonly employed in other high tech industries such as fine chemicals, automotive, aerospace, etc.) into pharmaceutical drug development. Unfortunately, this hurts the sustainability of the health system of which these products will be a part in the future. A desirable future state is the one that integrates fundamentals of economics in product design and development so that the decision-making is parameterized, the cost of goods could be lowered, wastage can be reduced, patient-centricity is built into the design, and manufacturing/distribution efficiencies can be gained. The financial benefits of such an approach could allow for these savings to be passed on to the stakeholders and improve the value proposition of pharmaceuticals, which is critical to maintaining the innovation potential. This book hopes to introduce the reader to this desired future state of pharmaceutical drug development. . Pharmacology. 67844 Pharmacy. 64666 Public health. 61312 Pharmaceutical chemistry. 67843 Epidemiology. 65983 Pharmacology. 67844 Pharmacy. 64666 Public Health. 61312 Pharmaceutics. 67846 Epidemiology. 65983 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031504143 Printed edition: 9783031504167 Printed edition: 9783031504174 AAPS Advances in the Pharmaceutical Sciences Series, 2210-738X ; 60 67850 https://doi.org/10.1007/978-3-031-50415-0 ZDB-2-SBL ZDB-2-SXB 63047 63047